Found: 115
Select item for more details and to access through your institution.
Intra-atrial re-entrant tachycardia in patients with congenital heart disease: factors associated with disease severity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Predictors of acute inefficacy and the radiofrequency energy time required for cavotricuspid isthmus-dependent atrial flutter ablation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intra-atrial re-entrant tachycardia in congenital heart disease: types and relation of isthmus to atrial voltage.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab329
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12669-5
- By:
- Publication type:
- Article
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 3, p. 581, doi. 10.3201/eid3003.231488
- By:
- Publication type:
- Article
Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 3, p. 585, doi. 10.3201/eid2903.220986
- By:
- Publication type:
- Article
Bilateral testicular germ cell tumours: a single hospital experience.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 4, p. 299, doi. 10.1007/s12094-010-0507-7
- By:
- Publication type:
- Article
Molecular basis for the treatment of renal cell carcinoma.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 1, p. 15, doi. 10.1007/s12094-010-0461-4
- By:
- Publication type:
- Article
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 995, doi. 10.3390/ijms18050995
- By:
- Publication type:
- Article
Decentralized Clinical Trials in Early Drug Development--A Framework Proposal.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 190, doi. 10.36401/JIPO-23-33
- By:
- Publication type:
- Article
Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 1, p. 7, doi. 10.36401/JIPO-23-2
- By:
- Publication type:
- Article
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16588-3
- By:
- Publication type:
- Article
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North‐Eastern Spain.
- Published in:
- Transboundary & Emerging Diseases, 2022, v. 69, n. 6, p. 3518, doi. 10.1111/tbed.14714
- By:
- Publication type:
- Article
Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies.
- Published in:
- Transboundary & Emerging Diseases, 2021, v. 68, n. 4, p. 1721, doi. 10.1111/tbed.13861
- By:
- Publication type:
- Article
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 124, doi. 10.1007/s10637-021-01184-5
- By:
- Publication type:
- Article
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 829, doi. 10.1007/s10637-020-01043-9
- By:
- Publication type:
- Article
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 193, doi. 10.1007/s10637-020-00944-z
- By:
- Publication type:
- Article
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1570, doi. 10.1007/s10637-020-00910-9
- By:
- Publication type:
- Article
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 76, doi. 10.1007/s10637-018-0602-0
- By:
- Publication type:
- Article
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 271, doi. 10.1007/s10637-018-0627-4
- By:
- Publication type:
- Article
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 476, doi. 10.1007/s10637-017-0546-9
- By:
- Publication type:
- Article
A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 710, doi. 10.1007/s10637-015-0241-7
- By:
- Publication type:
- Article
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 357, doi. 10.1007/s10637-014-0192-4
- By:
- Publication type:
- Article
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.646676
- By:
- Publication type:
- Article
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46714-w
- By:
- Publication type:
- Article
R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026060
- By:
- Publication type:
- Article
Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice.
- Published in:
- BMC Cardiovascular Disorders, 2012, v. 12, n. 1, p. 42, doi. 10.1186/1471-2261-12-42
- By:
- Publication type:
- Article
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer: Alexandra Leary.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12501-5
- By:
- Publication type:
- Article
Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 5, p. 1, doi. 10.1371/journal.ppat.1009229
- By:
- Publication type:
- Article
Preprocedural imaging to guide transcoronary ethanol ablation for refractory septal ventricular tachycardia.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2019, v. 30, n. 3, p. 448, doi. 10.1111/jce.13816
- By:
- Publication type:
- Article
Incremental Pacing for the Diagnosis of Complete Cavotricuspid Isthmus Block During Radiofrequency Ablation of Atrial Flutter.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2010, v. 21, n. 1, p. 33, doi. 10.1111/j.1540-8167.2009.01562.x
- By:
- Publication type:
- Article
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1016201
- By:
- Publication type:
- Article
Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 5, p. 796, doi. 10.1111/bcp.12256
- By:
- Publication type:
- Article
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1137, doi. 10.3390/cancers16061137
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3695, doi. 10.3390/cancers14153695
- By:
- Publication type:
- Article
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1538, doi. 10.3390/cancers13071538
- By:
- Publication type:
- Article
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2307, doi. 10.3390/cancers12082307
- By:
- Publication type:
- Article
New clinical trial designs in the era of precision medicine.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 3, p. 549, doi. 10.1002/1878-0261.12465
- By:
- Publication type:
- Article
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1263, doi. 10.1002/1878-0261.12099
- By:
- Publication type:
- Article
Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11262-x
- By:
- Publication type:
- Article
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 670, doi. 10.1007/s10637-014-0082-9
- By:
- Publication type:
- Article
Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6877
- By:
- Publication type:
- Article
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.744112
- By:
- Publication type:
- Article
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1291972
- By:
- Publication type:
- Article
Enhanced antiviral immunity and dampened inflammation in llama lymph nodes upon MERS-CoV sensing: bridging innate and adaptive cellular immune responses in camelid reservoirs.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1205080
- By:
- Publication type:
- Article